Vitamin K antagonist

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
File:Menaquinone.svg
Vitamin K2 (menaquinone). In menaquinone the side chain is composed of a varying number of isoprenoid residues.

WikiDoc Resources for Vitamin K antagonist

Articles

Most recent articles on Vitamin K antagonist

Most cited articles on Vitamin K antagonist

Review articles on Vitamin K antagonist

Articles on Vitamin K antagonist in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Vitamin K antagonist

Images of Vitamin K antagonist

Photos of Vitamin K antagonist

Podcasts & MP3s on Vitamin K antagonist

Videos on Vitamin K antagonist

Evidence Based Medicine

Cochrane Collaboration on Vitamin K antagonist

Bandolier on Vitamin K antagonist

TRIP on Vitamin K antagonist

Clinical Trials

Ongoing Trials on Vitamin K antagonist at Clinical Trials.gov

Trial results on Vitamin K antagonist

Clinical Trials on Vitamin K antagonist at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Vitamin K antagonist

NICE Guidance on Vitamin K antagonist

NHS PRODIGY Guidance

FDA on Vitamin K antagonist

CDC on Vitamin K antagonist

Books

Books on Vitamin K antagonist

News

Vitamin K antagonist in the news

Be alerted to news on Vitamin K antagonist

News trends on Vitamin K antagonist

Commentary

Blogs on Vitamin K antagonist

Definitions

Definitions of Vitamin K antagonist

Patient Resources / Community

Patient resources on Vitamin K antagonist

Discussion groups on Vitamin K antagonist

Patient Handouts on Vitamin K antagonist

Directions to Hospitals Treating Vitamin K antagonist

Risk calculators and risk factors for Vitamin K antagonist

Healthcare Provider Resources

Symptoms of Vitamin K antagonist

Causes & Risk Factors for Vitamin K antagonist

Diagnostic studies for Vitamin K antagonist

Treatment of Vitamin K antagonist

Continuing Medical Education (CME)

CME Programs on Vitamin K antagonist

International

Vitamin K antagonist en Espanol

Vitamin K antagonist en Francais

Business

Vitamin K antagonist in the Marketplace

Patents on Vitamin K antagonist

Experimental / Informatics

List of terms related to Vitamin K antagonist

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Vitamin K antagonists (VKA) are a class of anticoagulants which, as their name indicates, act by inhibiting the action of vitamin K.

They can be teratogens.[1]

Coumarins

Coumarins are the most commonly used VKA, and sometimes the terms are used synonymously.

In medicine, the most commonly used VKA is warfarin.[2] The primary mechanism of warfarin is the inhibition of vitamin K epoxide reductase.

VKAs are also used as rodenticides.[3]

Other VKAs

Not all VKAs are coumarins. For example, fluindione is a VKA,[4] but not a coumarin.

Another example is phenindione.[5]

Many of the non-coumarin VKAs are 1,3-indandione derivatives.

Tioclomarol is another VKA,[6] but it is neither a coumarin nor a diketone.

Related chapters

References

  1. Schaefer C, Hannemann D, Meister R; et al. (2006). "Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study". Thromb. Haemost. 95 (6): 949–57. doi:10.1160/TH06-02-0108. PMID 16732373. Unknown parameter |month= ignored (help)
  2. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G (2008). "Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)". Chest. 133 (6 Suppl): 160S–198S. doi:10.1378/chest.08-0670. PMID 18574265. Unknown parameter |month= ignored (help)
  3. Griminger P (1987). "Vitamin K antagonists: the first 50 years". J. Nutr. 117 (7): 1325–9. PMID 3302140. Unknown parameter |month= ignored (help)
  4. Mentré F, Pousset F, Comets E; et al. (1998). "Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients". Clin. Pharmacol. Ther. 63 (1): 64–78. doi:10.1016/S0009-9236(98)90122-9. PMID 9465843. Unknown parameter |month= ignored (help)
  5. "Foreword: contemporary issues in the management and treatment of atrial fibrillation -- Agnelli 7 (2005): C3 -- European Heart Journal Supplements". Retrieved 2008-12-22.
  6. "ATC/DDD Index". Retrieved 2008-12-23.

Template:Rodenticides


Template:WH Template:WS